Stock listing

8EQ Stock Price, News, Filings & Events — Cytek Biosciences, Inc.

Selected listing: 8EQ · GETTEX · EUR · DE

This page tracks Cytek Biosciences, Inc.'s 8EQ:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 8EQ:GETTEX. 8EQ:GETTEX is the stock-level entry point for investors researching Cytek Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cytek Biosciences, Inc. (ticker: CTKB) is a public company based in the United States, specializing in advanced cell analysis technologies. With a market capitalization of approximately $576 million, Cytek is focused on providing innovative solutions for researchers in the life sciences sector. The company's products enhance the understanding of complex biological systems, supporting advancements in various fields, including...

8EQ:GETTEXEURDEUpdated August 28, 2026
Cytek Biosciences, Inc. logo
Ticker
8EQ:GETTEX
Asset type
Stock
Market cap
$608.3M
Sector
Health Technology
Industry
Medical Specialties
Exchange
GETTEX
Currency
EUR

Cytek Biosciences, Inc. 8EQ:GETTEX stock context

This page tracks Cytek Biosciences, Inc.'s 8EQ:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 8EQ:GETTEX. 8EQ:GETTEX is the stock-level entry point for investors researching Cytek Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cytek Biosciences, Inc. (ticker: CTKB) is a public company based in the United States, specializing in advanced cell analysis technologies. With a market capitalization of approximately $576 million, Cytek is focused on providing innovative solutions for researchers in the life sciences sector. The company's products enhance the understanding of complex biological systems, supporting advancements in various fields, including...

Latest news from Cytek Biosciences, Inc.

All Cytek Biosciences, Inc. news →

Cytek Biosciences, Inc. earnings calls

Research Cytek Biosciences, Inc.

Alternate listings